Prism Clinical Research collaborates with University of Minnesota researchers in COVID-19 prevention treatment study for healthcare workers

Via Nucleus Network

< Back to news

Prism Clinical Research collaborates with University of Minnesota researchers in COVID-19 prevention treatment study for healthcare workers

Via Nucleus Network

“Prism Clinical Research (a Nucleus Network company) is playing a key role in supporting the University of Minnesota as it commences trialling a COVID-19 prevention treatment targeting frontline healthcare workers and first responders.”

“David Boulware, MD, MPH, a professor in the University of Minnesota Medical School’s Department of Medicine in the Division of Infectious Diseases and International Medicine, leads the trial with a collaborative team from the University, including infectious disease faculty physicians, biostatisticians, pharmacologists and students.”

“Principal Investigator Radha Rajasingham, MD, is an assistant professor in the Medical School’s Department of Medicine in the Division of Infectious Diseases and International Medicine.”

“’We are working with Prism Research for their pharmacy services and I want to thank Prism Research for supporting our study,’ said Dr Rajasingham, who is working on the ‘Pre-exposure Prophylaxis for SARS-Coronavirus 2: A pragmatic randomized clinical trial.’”

See more about the hydroxychloroquine trial Prism Clinical Research and the University of Minnesota are working on.

MAA COVID-19 INFORMATION DISCLAIMER:

The Medical Alley Association is providing COVID-19 related information, including the “COVID-19 Resource Connect” feature on its website and summaries of laws, executive orders, and government programs that may be of interest to members, as a public service.   The Medical Alley Association makes no representations, guarantees, or warranties as to the accuracy, completeness, currency, or suitability of the COVID-19 related information provided by the Medical Alley Association on its website, in newsletters, or in any other communications. The Medical Alley Association specifically disclaims any and all liability for any claims or damages that may result from providing COVID-19 related information online or in other communications or linking to third party websites or other sources of information. The Medical Alley Association makes no effort to independently verify, and does not exert editorial control over, information provided by third parties.  

The Medical Alley Association does not endorse any of the products, vendors, consultants, or documentation referenced in, or connected to parties through, the COVID-19 Resource Connect feature or via email or other communications.

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER